Endothelial nitric oxide synthase T(-786)C polymorphism in children and adolescents with type 1 diabetes and impaired endothelium-dependent dilatation

Hormone Research in Paediatrics

Volumn 76, Issue 4, 2011, Pages 248-253

  Battelino, Nina ^a   Sebestjen, Miran ^b   Keber, Irena ^b   Blagus, Rok ^c   Hovnik, Tinka ^a   Bratina, Natasa ^a   Battelino, Tadej ^a,c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Chronic complications; Endothelium dependent dilatation; eNOS polymorphism; Type 1 diabetes mellitus

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; BRACHIAL ARTERY; CHILD; DIABETES MELLITUS, TYPE 1; ENDOTHELIUM, VASCULAR; FEMALE; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; VASOCONSTRICTION; VASODILATION;

EID: 80054947838     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000329549     Document Type: Article

References (26)

1. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study research group: intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653.
2. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ: The 30-year natural history of type 1 diabetes complications: the Pittsburg Epidemiology of Diabetes Complications study experience. Diabetes 2006; 55: 1463-1469. (Pubitemid 44195388)
3. Järvisalo MJ, Raitakari M, Toikka JO, Putto- Laurila A, Rontu R, et al.: Endothelial dysfunction and increased arterial intima-media thickness in children with type I diabetes. Circulation 2004; 109: 1750-1755. (Pubitemid 38500678)
4. Singh TP, Groehn H, Kazmers A: Vascular function and carotid intimal medial thickness in children with insulin dependent diabetes mellitus. J Am Coll Cardiol 2003; 41: 661-665. (Pubitemid 36223334)
5. Farkas K, Jermendy G, Herold M, Ruzicska E, Sasvari M, Somogyi A: Impairment of the NO/cGMP pathway in the fasting and postprandial state in type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 2004; 112: 258-263. (Pubitemid 38679270)
6. Bolego C, Buccellati C, Radelli T, Cetin I, Puglisi L, Folco G, Sala A: eNOS, COX-2 and prostacyclin production are impaired in endothelial cells from diabetics. Biochem Biophys Res Commun 2006; 339: 188-190. (Pubitemid 41697533)
7. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F: Gene structure polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994; 198: 1027-1033. (Pubitemid 24172800)
8. Zintzaras E, Kitsios G, Stefanidis I: Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 2006; 48: 700-710. (Pubitemid 44843875)
9. Casas JP, Bautista LE, Humphries SE, Hingorani AD: Endothelial nitric oxide synthase genotype and ischemic heart disease: metaanalysis of 26 studies involving 23,028 subjects. Circulation 2004; 109: 1359-1365. (Pubitemid 38387821)
10. Wattanapitayakul SK, Mihm MJ, Young AP, Bauer JA: Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci 2001; 22: 361-368. (Pubitemid 32592475)
11. Nakayama M, Yasue H, Hoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, et al.: A T- 786 ] C mutation in the 59 flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-2870. (Pubitemid 29258973)
12. Miyamoto Y, Saito Y, Nakayama M, et al.: Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T ] C mutation associated with coronary spastic angina. Hum Mol Genet 2002; 9: 2629-2637.
13. Zineh I, Beitelshees AL, Haller MJ: NOS 3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes. Diabetes Care 2007; 30: 689-693. (Pubitemid 46354354)
14. Rossi GP, Cesari M, Zanchetta M, Colonna S, Maiolino G, Pedon L, Cavallin M, Maiolino P, Pessina AC: The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 2003; 41: 930-937. (Pubitemid 36315532)
15. Komatsu M, Kawagiski T, Emoto M, Shoji T, Yamada A, Sato K, Hosoi M, Nishizawa Y: ecNOS gene polymorphism is associated with endothelium-dependent vasodilatation in type 2 diabetes. Am J Physiol Heart Circ Physiol 2002; 283:H557-H561. (Pubitemid 34790848)
16. Tanner JM: Normal growth and techniques of growth assessment. Clin Endocrinol Metab 1986; 15: 411-451.
17. Celermajer DS, Sorensen KE, Gooch VM, et al.: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
18. Järvisalo MJ, Ro{combining double acute accent}nnemaa T, Volanen I, Kaitosaari T, Hartiala JJ, Irjala K, Viikari JS, Simell O, Raitakari OT: Brachial artery dilatation responses in healthy children and adolescents. Am J Physiol Heart Circ Physiol 2002; 282:H87-H92.
19. Amolli MM, Garcia-Porrua C, Llorca J, Ollier WE, Gonzales-Gay MA: Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis. J Reumatol 2003; 30: 2019-2022. (Pubitemid 37075555)
20. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K: International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practise Consensus Guidelines 2006-2007. Pediatr Diabetes 2007; 8: 163-170.
21. El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M: Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med 2008; 205: 2409-2417.
22. Shah AS, Dolan LM, Kimball TR, Gao Z, Khowry PR, Daniels SR, Urbina EM: Influence of duration of diabetes, glycemic control and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes. J Clin Endocrinol Metab 2009; 94: 3740-3745.
23. Taverna MJ, Elgrably F, Selmi H, Selam JL, Slama G: The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy. Nitric Oxide 2005; 13: 88-92. (Pubitemid 40853973)
24. Awata T, Neda T, Iizuka H, Kurihara S, Ohkubo T, Takata N, Osaki M, Watanabe M, Nakashima Y, Sawa T, Inukai K, Inoue I, Shibuya M, Mori K, Yoneya S, Katayama S: Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type 2 diabetes. Diabetes Care 2004; 27: 2184-2190. (Pubitemid 39167183)
25. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS: Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000; 57: 405-413. (Pubitemid 30430632)
26. Rittig K, Holder K, Stock J, Tschritter O, Peter S, Stefan N, Fritsche A, Machicao F, Häring HU, Balletshofer B: Endothelial NOsynthase intron 4 polymorphism is associated with disturbed in vivo nitric oxide production in individuals prone to type 2 diabetes. Horm Metab Res 2008; 40: 13-17. (Pubitemid 351204819)